Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	501.59	71.99	11.97
Graham Fair Price	17.96	79126.70	67078.17
PEG	3218.94	0.10	< 0.005
Price/Book	-6.14	0.19	0.21
Price/Cash Flow	-20.17	18.61	23.32
Prices/Earnings	-34.53	4.19	6.41
Price/Sales	-24.52	1.15	1.52
Price/FCF	-20.17	18.61	23.32
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-24.84	0.14	0.18
Operating Margin	-91.55	< 0.005	0.03
ROA	47.32	< 0.005	< 0.005
ROE	< 0.005	0.01	43.35
ROIC	< 0.005	< 0.005	-89.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.28	-0.05	-428.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	5.25	-1.10	-78.99
EPS QOQ	20.90	0.41	-98.03
FCF QOQ	3.69	0.16	-95.71
Revenue QOQ	-0.18	0.23	24.36
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	140.84	103.87	-26.25
Days Sales Outstanding (DSO)	71.79	71.76	-0.04
Inventory Turnover	0.64	0.87	35.60
Debt/Capitalization	0.12	0.09	-24.24
Quick Ratio	1.54	1.98	28.91
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	157416.53	155092.09	-1.48
Cash	40396.67	41849.27	3.60
Capex	-139.79	31.97	-77.13
Free Cash Flow	1395.96	1616.99	15.83
Revenue	21430.89	26255.58	22.51
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.32	2.79	20.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.54	14.65	314.26
Naive Interpretation	Member

06 - Financial Health · Bad

Rating